Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002037144-25-000003
Filing Date
2025-09-22
Accepted
2025-09-22 21:25:04
Documents
1
Period of Report
2025-09-18

Document Format Files

Seq Description Document Type Size
1 form4-09222025_090901.html 4  
1 form4-09222025_090901.xml 4 3632
  Complete submission text file 0002037144-25-000003.txt   5280
Mailing Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 (650) 457-1978
Structure Therapeutics Inc. (Issuer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O STRUCTURE THERAPEUTICS INC. 601 GATEWAY BLVD., SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address
Coll Crespo Blas (Reporting) CIK: 0002037144 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41608 | Film No.: 251331566